NARI has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NARI has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2024-05-16), Inari Medical's 12-1 Month Momentum % is -44.51%.
The industry rank for Inari Medical's 12-1 Month Momentum % or its related term are showing as below:
For the Medical Devices subindustry, Inari Medical's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, Inari Medical's 12-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where Inari Medical's 12-1 Month Momentum % falls into.
12-1 Month Momentum % is calculated as following:
12-1 Month Momentum % | = | ( Price 1-month ago | / | Price 12-month ago | - 1 ) | * | 100 % |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Inari Medical (NAS:NARI) 12-1 Month Momentum % Explanation
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
Thank you for viewing the detailed overview of Inari Medical's 12-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.
William Hoffman | director, officer: President and CEO | C/O INARI MEDICAL, INC., 9 PARKER, SUITE 100, IRVINE CA 92618 |
Mitch C. Hill, | officer: Chief Financial Officer | 1009 TENNYSON DRIVE, SOUTHLAKE TX 76902 |
Andrew Hykes | officer: Chief Operating Officer | C/O INARI MEDICAL, INC., 9 PARKER AVENUE, SUITE 100, IRVINE CA 92618 |
Thomas Tu | officer: Chief Medical Officer | C/O INARI MEDICAL, INC., 9 PARKER AVENUE, SUITE 100, IRVINE CA 92618 |
Donald B Milder | director | ONE SANSOME STREET, SUITE 1650, SAN FRANCISCO CA 94104 |
Robert Keith Warner | director | C/O RXSIGHT, INC., 100 COLUMBIA, ALISO VIEJO CA 92656 |
Catherine M. Szyman | director | C/O EDWARDS LIFESCIENCES CORPORATION, ONE EDWARDS WAY, IRVINE CA 92614 |
Cynthia L Lucchese | director | 7966 N. ILLINOIS STREET, INDIANAPOLIS IN 46260 |
Mead Dana G Jr. | director | 2750 SAND HILL ROAD, MENLO PARK CA 94025 |
Rebecca Chambers | director | 3052 ORCHARD DR., SAN JOSE CA 95134 |
Jonathan D Root | director | 2735 SAND HILL ROAD, MENLO PARK CA 94025 |
Cooperatieve Gilde Healthcare Iv U.a. | 10 percent owner | NEWTONLANN 51, UTRECHT P7 3508AB |
Kirk G. Nielsen | director, 10 percent owner | ONE SANSOME STREET, SUITE 3630, SAN FRANCISCO CA 94104 |
Gilde Healthcare Iv Management B.v. | 10 percent owner | NEWTONLAAN 91, UTRECHT P7 3584 BP |
Gilde Healthcare Holding B.v. | 10 percent owner | NEWTONLAAN 91, PO BOX 85067, 3508 UTRECHT P7 AB |
From GuruFocus
By Stock market mentor Stock market mentor • 01-31-2023
By GuruFocus Research • 09-14-2023
By PRNewswire • 01-08-2024
By Marketwired • 10-11-2023
By GuruFocus Research • 10-19-2023
By Marketwired • 07-26-2023
By GlobeNewswire • 11-27-2023
By GuruFocus Research GuruFocus Editor • 05-20-2023
By GuruFocus Research GuruFocus Editor • 11-17-2022
By GuruFocus Research GuruFocus Editor • 05-19-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.